UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000016039 |
|---|---|
| Receipt number | R000018644 |
| Scientific Title | Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease-III |
| Date of disclosure of the study information | 2014/12/24 |
| Last modified on | 2025/07/08 13:02:31 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease-III
Acronym
Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease-III (FIBROELAST-III Study)
Scientific Title
Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease-III
Scientific Title:Acronym
Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease-III (FIBROELAST-III Study)
Region
| Japan |
Condition
Condition
All patients liver resection is scheduled
Classification by specialty
| Hepato-biliary-pancreatic medicine | Hepato-biliary-pancreatic surgery |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Study of correlation between elastography results and liver tissue pathology diagnosis
Study of the correlation between the various elastography
Calculation of liver pathology diagnostic algorithm
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Study of correlation between elastography results and liver tissue pathology diagnosis
Calculation of liver pathology diagnostic algorithm
Key secondary outcomes
Study of the correlation between the various elastography
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
(1) All patients liver resection is scheduled
(2) Men and women over the age of 20
(3) After receiving a sufficient explanation Upon participation in the the study, on a full understanding, patients who obtained the document voluntary consent of the patient himself
Key exclusion criteria
(1) There are tumor of more than 3cm it is entered of ROI in right lobe.
(2) Patients or lactating patients, suspected of being pregnant pregnant women
(3) In addition, patients that research attending physician is deemed inappropriate
Target sample size
300
Research contact person
Name of lead principal investigator
| 1st name | Masatoshi |
| Middle name | |
| Last name | Kudo |
Organization
Kindai University Faculty of Medicine
Division name
Department of Gastroenterology and Hepatology
Zip code
589-8511
Address
377-2 Ohno-Higashi, Osaka-Sayama, Osaka 589-8511, Japan
TEL
072-366-0221
m-kudo@med.kindai.ac.jp
Public contact
Name of contact person
| 1st name | Norihisa |
| Middle name | |
| Last name | Yada |
Organization
Kindai University Faculty of Medicine
Division name
Department of Gastroenterology and Hepatology
Zip code
589-8511
Address
377-2 Ohno-Higashi, Osaka-Sayama, Osaka 589-8511, Japan
TEL
072-366-0221
Homepage URL
yada@med.kindai.ac.jp
Sponsor or person
Institute
Health and Labour Sciences Research
Grants for the Research on Hepatitis
Institute
Department
Personal name
Funding Source
Organization
Health and Labour Sciences Research
Grants for the Research on Hepatitis
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
377-2 Ohno-higashi, Osaka-Sayama City, Osaka 589-8511, Japan
Address
Kindai University Faculty of Medicine, Ethics Committee
Tel
072-366-0221
zizen@med.kindai.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2014 | Year | 12 | Month | 24 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2014 | Year | 10 | Month | 17 | Day |
Date of IRB
| 2014 | Year | 09 | Month | 01 | Day |
Anticipated trial start date
| 2014 | Year | 10 | Month | 21 | Day |
Last follow-up date
| 2018 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Multicenter observational study
Management information
Registered date
| 2014 | Year | 12 | Month | 24 | Day |
Last modified on
| 2025 | Year | 07 | Month | 08 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018644
